Covered recipient · General Payments record
CHRISTOPHER D WELLS
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$3,657.10
- Reported across 156 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $494.16 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $354.12 | 26 |
| PFIZER INC. | $31.26 | 2 |
| Fresenius Kabi USA, LLC | $27.24 | 2 |
| Ardelyx, Inc. | $19.11 | 1 |
| Janssen Biotech, Inc. | $17.61 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $15.52 | 1 |
| INTERCEPT PHARMACEUTICALS, INC. | $15.10 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.20 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $7.91 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106324739 | CMS |
| ABBVIE INC. | $6.28 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106324741 | CMS |
| ABBVIE INC. | $19.65 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106324743 | CMS |
| ABBVIE INC. | $20.79 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106324745 | CMS |
| ABBVIE INC. | $23.44 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106324747 | CMS |
| ABBVIE INC. | $7.91 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106324749 | CMS |
| ABBVIE INC. | $13.23 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106324751 | CMS |
| ABBVIE INC. | $7.60 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106324753 | CMS |
| ABBVIE INC. | $14.69 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106324755 | CMS |
| ABBVIE INC. | $2.50 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106324757 | CMS |
| ABBVIE INC. | $15.72 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106324759 | CMS |
| ABBVIE INC. | $7.58 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106324761 | CMS |
| ABBVIE INC. | $11.80 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106324763 | CMS |
| ABBVIE INC. | $19.78 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106324765 | CMS |
| ABBVIE INC. | $22.52 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106324767 | CMS |
| ABBVIE INC. | $15.02 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106324769 | CMS |
| ABBVIE INC. | $9.71 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106324771 | CMS |
| ABBVIE INC. | $13.62 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106324773 | CMS |
| ABBVIE INC. | $17.26 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106324775 | CMS |
| ABBVIE INC. | $6.17 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106324777 | CMS |
| ABBVIE INC. | $12.12 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106324779 | CMS |
| ABBVIE INC. | $8.04 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106324781 | CMS |
| ABBVIE INC. | $18.05 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106324783 | CMS |
| ABBVIE INC. | $13.03 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106324785 | CMS |
| ABBVIE INC. | $18.59 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106324787 | CMS |
| ABBVIE INC. | $21.11 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106324789 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $15.52 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146975690 | CMS |
| Ardelyx, Inc. | $19.11 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146713883 | CMS |
| Fresenius Kabi USA, LLC | $13.62 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146957747 | CMS |
| Fresenius Kabi USA, LLC | $13.62 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146957749 | CMS |
| Intercept Pharmaceuticals, Inc. | $15.10 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113632046 | CMS |
| Janssen Biotech, Inc. | $17.61 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078473103 | CMS |
| PFIZER INC. | $14.25 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132074801 | CMS |
| PFIZER INC. | $17.01 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131180907 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.20 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137696580 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.